Back Bay in the Boston Globe: Challenge for Cancer Drug Startups

Back Bay’s Managing Partner and CEO, Jonathan Gertler, was quoted in Boston Globe article “Independence is a constant challenge for cancer drug startups” by Robert Weisman posted on January 27. From the article:

“There’s an enormous amount of oncology expertise here, and a large concentration of cancer research grants,” said biopharma consultant Jonathan Gertler, co-founder and chief executive of Back Bay Life Science Advisors in Boston. “[But] ultimately everybody is for sale. The majority of small biotech companies, if successful, will eventually be acquired.” 

Read More at the Globe:  Independence is a constant challenge for cancer drug startups